American biotechnology company Moderna announced recently that they commit to distributing six million vaccines upon the emergency use authorization of the U.S. FDA.
The U.S. Food and Drug Administration (FDA) gave emergency use authorization to Pfizer's COVID-19 vaccine on Friday night, paving the way for the millions of vulnerable individuals to get inoculated within days.
White House Chief of Staff Mark Meadows said Food and Drug Administration (FDA) Commissioner Stephen Hahn's job could be on the line if his agency will not quickly approve Pfizer Inc.'s COVID-19 vaccine.
Pfizer's COVID-19 vaccine will be going through an FDA committee vote on Thursday, the last step to reach approval, as two allergic reactions reported in the UK raised concerns.
The Pfizer coronavirus vaccine is poised to get approval from the U.S. Food and Drug Administration (FDA) after a scientific evaluation released on Tuesday confirmed it offered strong protection.
In early December 2020, a blog called Health and Money News claimed that a "head of Pfizer research" said the COVID-19 vaccine could cause female sterilization. But was it really said?
Pfizer announced on Wednesday that its coronavirus vaccine developed with partner BioNTech is more than 95 percent effective during the final analysis of its Phase 3 trial.
Early data from Moderna's late-stage clinical trial revealed that its COVID-19 vaccine gives nearly 95 percent protection against the infectious and deadly COVID-19.
A total of 20 million Americans could be vaccinated with Pfizer's COVID-19 vaccine before the end of the year, according to a top official involved in the government's vaccine initiative.
Moderna is one of the leading American biotechnology companies that aims to develop a COVID-19 vaccine. The company announced that will it soon release the status of their vaccine.
Health experts had raised some concerns over Pfizer's COVID-19 vaccine. They said that the shot might be safe and effective, but many questions are left unanswered.
The COVID-19 vaccine developed by Pfizer Inc. and its partner BioNTech proved to be 90% effective in protecting the people against the virus in a pivotal study.
